Skip to menu Skip to content Skip to footer

2016

Journal Article

Dynorphin 1-17 and Its N-Terminal Biotransformation Fragments Modulate Lipopolysaccharide-Stimulated Nuclear Factor-kappa B Nuclear Translocation, Interleukin-1beta and Tumor Necrosis Factor-alpha in Differentiated THP-1 Cells

Fazalul Rahiman, Siti Sarah, Morgan, Michael, Gray, Paul, Shaw, Paul Nicholas and Cabot, Peter John (2016). Dynorphin 1-17 and Its N-Terminal Biotransformation Fragments Modulate Lipopolysaccharide-Stimulated Nuclear Factor-kappa B Nuclear Translocation, Interleukin-1beta and Tumor Necrosis Factor-alpha in Differentiated THP-1 Cells. PLoS One, 11 (4) e0153005, e0153005.1-e0153005.18. doi: 10.1371/journal.pone.0153005

Dynorphin 1-17 and Its N-Terminal Biotransformation Fragments Modulate Lipopolysaccharide-Stimulated Nuclear Factor-kappa B Nuclear Translocation, Interleukin-1beta and Tumor Necrosis Factor-alpha in Differentiated THP-1 Cells

2016

Journal Article

Neuronal nicotinic acetylcholine receptor modulators reduce sugar intake

Shariff, Masroor, Quik, Maryka, Holgate, Joan, Morgan, Michael, Patkar, Omkar L., Tam, Vincent, Belmer, Arnauld and Bartlett, Selena E. (2016). Neuronal nicotinic acetylcholine receptor modulators reduce sugar intake. PLoS One, 11 (3) e0150270, 1-15. doi: 10.1371/journal.pone.0150270

Neuronal nicotinic acetylcholine receptor modulators reduce sugar intake

2016

Journal Article

EPHA4-FC treatment reduces ischemia/reperfusion-induced intestinal injury by inhibiting vascular permeability

Woodruff, Trent M., Wu, Mike C.-L., Morgan, Michael, Bain, Nathan T., Jeanes, Angela, Lipman, Jeffrey, Ting, Michael J., Boyd, Andrew W., Taylor, Stephen M. and Coulthard, Mark G. (2016). EPHA4-FC treatment reduces ischemia/reperfusion-induced intestinal injury by inhibiting vascular permeability. Shock, 45 (2), 184-191. doi: 10.1097/SHK.0000000000000494

EPHA4-FC treatment reduces ischemia/reperfusion-induced intestinal injury by inhibiting vascular permeability

2016

Journal Article

The antihypertensive drug pindolol attenuates long-term but not short-term binge-like ethanol consumption in mice

Patkar, Omkar L., Belmer, Arnauld, Holgate, Joan Y., Tarren, Josephine R., Shariff, Masroor R., Morgan, Michael, Fogarty, Matthew J., Bellingham, Mark C., Bartlett, Selena E. and Klenowski, Paul M. (2016). The antihypertensive drug pindolol attenuates long-term but not short-term binge-like ethanol consumption in mice. Addiction Biology, 22 (3), 679-691. doi: 10.1111/adb.12359

The antihypertensive drug pindolol attenuates long-term but not short-term binge-like ethanol consumption in mice

2016

Conference Publication

Peripheral kappa-opioid receptor (KOR) stimulation exerts anti-inflammatory effects in lipopolysaccharide (LPS)-activated macrophages

Rahiman, Fazalul S. S., Morgan, M., Gray, P., Shaw, P. and Cabot, P. (2016). Peripheral kappa-opioid receptor (KOR) stimulation exerts anti-inflammatory effects in lipopolysaccharide (LPS)-activated macrophages. ICI 2016 International Congress of Immunology, Melbourne, VIC Australia, 21-26 August 2016. Weinheim, Germany: Wiley-Blackwell. doi: 10.1002/eji.201670200

Peripheral kappa-opioid receptor (KOR) stimulation exerts anti-inflammatory effects in lipopolysaccharide (LPS)-activated macrophages

2015

Conference Publication

A novel treatment approach for obesity and over-weight - targeting brain nicotinic receptors with Champix

Shariff, M., Klenowski, P., Morgan, M., Holgate, J., Belmer, A., Patkar, O. and Bartlett, S. (2015). A novel treatment approach for obesity and over-weight - targeting brain nicotinic receptors with Champix. 25th Biennial Meeting of the International Society for Neurochemistry Jointly with the 13th Meeting of the Asian Pacific Society for Neurochemistry in Conjunction with the 35th Meeting of the Australasian Neuroscience Society, Cairns, Australia, Aug 23-27, 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

A novel treatment approach for obesity and over-weight - targeting brain nicotinic receptors with Champix

2015

Conference Publication

Pindolol, an FDA approved antihypertensive drug, decreases ethanol consumption in mice following long but not short-term exposure

Patkar, O., Klenowski, P., Tarren, J., Holgate, J., Shariff, M., Morgan, M., Molenaar, P. and Bartlett, S. (2015). Pindolol, an FDA approved antihypertensive drug, decreases ethanol consumption in mice following long but not short-term exposure. 25th Biennial Meeting of the International Society for Neurochemistry Jointly with the 13th Meeting of the Asian Pacific Society for Neurochemistry in Conjunction with the 35th Meeting of the Australasian Neuroscience Society, Cairns, Australia, Aug 23-27, 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Pindolol, an FDA approved antihypertensive drug, decreases ethanol consumption in mice following long but not short-term exposure

2015

Journal Article

The role of δ-opioid receptors in learning and memory underlying the development of addiction

Klenowski, Paul, Morgan, Michael and Bartlett, Selena E. (2015). The role of δ-opioid receptors in learning and memory underlying the development of addiction. British Journal of Pharmacology, 172 (2), 297-310. doi: 10.1111/bph.12618

The role of δ-opioid receptors in learning and memory underlying the development of addiction

2014

Journal Article

Biotransformation of beta-endorphin and possible therapeutic implications

Asvadi, Naghmeh H., Morgan, Michael, Hewavitharana, Amitha K., Shaw, P. Nicholas and Cabot, Peter J. (2014). Biotransformation of beta-endorphin and possible therapeutic implications. Frontiers in Pharmacology, 5 (Article 18) Article 18, 18. doi: 10.3389/fphar.2014.00018

Biotransformation of beta-endorphin and possible therapeutic implications

2014

Journal Article

Beta-Endorphin 1-31 Biotransformation and cAMP Modulation in Inflammation

Asvadi, Naghmeh Hajarol, Morgan, Michael, Herath, Herath M., Hewavitharana, Amitha K., Shaw, P. Nicholas and Cabot, Peter J. (2014). Beta-Endorphin 1-31 Biotransformation and cAMP Modulation in Inflammation. PLoS One, 9 (3) e90380, e90380.1-e90380.11. doi: 10.1371/journal.pone.0090380

Beta-Endorphin 1-31 Biotransformation and cAMP Modulation in Inflammation

2013

Conference Publication

The biotransformation of beta-endorphin in the rat brain after a single sedating dose of ethanol

Morgan, Michael, Holgate, Jan, Hewavitharana, Amitha K., Shaw, Nick, Cabot, Peter and Bartlett, Selena E. (2013). The biotransformation of beta-endorphin in the rat brain after a single sedating dose of ethanol. Australasian Professional Society on Alcohol and other Drugs Conference, Brisbane, QLD, Australia, 24-27 November 2013. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/dar.12077

The biotransformation of beta-endorphin in the rat brain after a single sedating dose of ethanol

2013

Conference Publication

Biotransformation within inflamed tissue of beta-endorphin 1-31 and three major N-terminal fragments; beta-endorphin 1-17, beta-endorphin 1-13, and beta-endorphin 1-11

Asvadi, Naghmeh Hajarol, Morgan, Michael, Hewavitharana, Amitha, Shaw, P. Nicholas and Cabot, Peter J. (2013). Biotransformation within inflamed tissue of beta-endorphin 1-31 and three major N-terminal fragments; beta-endorphin 1-17, beta-endorphin 1-13, and beta-endorphin 1-11. HPLC 2013: 40th International Symposium on High Performance Liquid Phase Separations and Related Techniques, Hobart, TAS, Australia, 18-21 November, 2013. Royal Australian Chemical Institute (raci).

Biotransformation within inflamed tissue of beta-endorphin 1-31 and three major N-terminal fragments; beta-endorphin 1-17, beta-endorphin 1-13, and beta-endorphin 1-11

2012

Journal Article

Dynorphin A 1–17 biotransformation in inflamed tissue, serum and trypsin solution analysed by liquid chromatography–tandem mass spectrometry

Morgan, M., Herath, H. M. D. R., Cabot, P. J., Shaw, P. N. and Hewavitharana, A. K. (2012). Dynorphin A 1–17 biotransformation in inflamed tissue, serum and trypsin solution analysed by liquid chromatography–tandem mass spectrometry. Analytical and Bioanalytical Chemistry, 404 (10), 3111-3121. doi: 10.1007/s00216-012-6406-8

Dynorphin A 1–17 biotransformation in inflamed tissue, serum and trypsin solution analysed by liquid chromatography–tandem mass spectrometry

2012

Journal Article

Eph/Ephrin signaling in injury and inflammation

Coulthard, Mark G., Morgan, Michael, Woodruff, Trent M., Arumugam, Thiruma V., Taylor, Stephen M., Carpenter, Todd C., Martin Lackmann, and Boyd, Andrew W. (2012). Eph/Ephrin signaling in injury and inflammation. American Journal of Pathology, 181 (5), 1493-1503. doi: 10.1016/j.ajpath.2012.06.043

Eph/Ephrin signaling in injury and inflammation

2012

Conference Publication

The efficacy of κ-opioid The efficacy of κ-opioid receptor agonists in pain and inflammation

Morgan, Michael (2012). The efficacy of κ-opioid The efficacy of κ-opioid receptor agonists in pain and inflammation. Australian Pharmaceutical Science Association Conference, Sydney, Australia, 2-5 December 2012.

The efficacy of κ-opioid The efficacy of κ-opioid receptor agonists in pain and inflammation

2010

Other Outputs

Preclinical Drug Development: The properties of the gastrointestinal tract that affect drug absorption and the pharmacology of gout

Michael Morgan (2010). Preclinical Drug Development: The properties of the gastrointestinal tract that affect drug absorption and the pharmacology of gout. PhD Thesis, School of Biomedical Sciences, The University of Queensland.

Preclinical Drug Development: The properties of the gastrointestinal tract that affect drug absorption and the pharmacology of gout

2009

Journal Article

Detection of anti-TNFα activity in canine hyperimmune serum using a TNFα inhibition assay

Kotiw, Michael, Morgan, Michael, Taylor, Stephen M. and Shiels, Ian A. (2009). Detection of anti-TNFα activity in canine hyperimmune serum using a TNFα inhibition assay. Veterinary Clinical Pathology, 39 (1), 46-52. doi: 10.1111/j.1939-165X.2009.00166.x

Detection of anti-TNFα activity in canine hyperimmune serum using a TNFα inhibition assay

2008

Journal Article

Pharmacokinetics of a C5a receptor antagonist in the rat after different sites of enteral administration

Morgan, Michael, Bulmer, Andrew C., Woodruff, Trent M., Proctor, Lavinia M., Williams, Hua M., Stocks, Shelli Z., Pollitt, Sandra, Taylor, Stephen M. and Shiels, Ian A (2008). Pharmacokinetics of a C5a receptor antagonist in the rat after different sites of enteral administration. European Journal of Pharmaceutical Sciences, 33 (4-5), 390-398. doi: 10.1016/j.ejps.2008.01.009

Pharmacokinetics of a C5a receptor antagonist in the rat after different sites of enteral administration

2007

Journal Article

A C5a receptor antagonist provides greater protection than an NSAID in a skin pouch model of sodium urate induced inflammation

Michael Morgan, Taylor, Stephen M. and Shiels, I (2007). A C5a receptor antagonist provides greater protection than an NSAID in a skin pouch model of sodium urate induced inflammation. Molecular Immunology, 44 (1-3), 217-217. doi: 10.1016/j.molimm.2006.07.164

A C5a receptor antagonist provides greater protection than an NSAID in a skin pouch model of sodium urate induced inflammation